Development in PET for the detection of endocrine tumours

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 19, Issue 2, 2005, Pages 311-324

  Eriksson, Barbaro ^a   Orlefors H ^a   Oberg K ^a   Sundin, A ^a   Bergstrom M ^a   Langstrom B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

6 (18F) fluorodopamine; 11C 5 hydroxytryptophan (5 HTP); 11C hydroxyephedrine; 11C l dihydroxyphenylalanine (l DOPA); 11C metomidate; 18F fluorodeoxyglucose (FDG); Endocrine tumours; Positron emission tomography (PET)

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; 3 HYDROXYEPHEDRINE; 3 METHYLSPIPERONE C 11; 5 HYDROXYTRYPTOPHAN; ADRENALIN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CARBON 11; CORTICOTROPIN; DOPA; DOPAMINE DERIVATIVE; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GLUCOSE TRANSPORTER; HISTAMINE; LEVODOPA; METHIONINE C 11; METOMIDATE; NITROGEN 13; OXYGEN 15; PENTETREOTIDE; PHENYLEPHRINE; RACLOPRIDE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; SELEGILINE; SEROTONIN; SOMATOSTATIN RECEPTOR; TRYPTOPHAN; UNINDEXED DRUG; CARBON; DIAGNOSTIC AGENT; FLUORINE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; APUD CELL; ARTICLE; BIOCHEMISTRY; CARCINOGENESIS; CARCINOID; CLINICAL RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DRUG HALF LIFE; DRUG TARGETING; ENDOCRINE TUMOR; FOLLOW UP; HUMAN; HYPOPHYSIS TUMOR; IN VIVO STUDY; PANCREAS TUMOR; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIMARY HYPERPARATHYROIDISM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURGICAL TECHNIQUE; THYROID MEDULLARY CARCINOMA; TISSUE DISTRIBUTION; TUMOR DIAGNOSIS; METHODOLOGY; NEUROENDOCRINE TUMOR; REVIEW; SCINTISCANNING;

CARBON RADIOISOTOPES; ENDOCRINE GLAND NEOPLASMS; FLUORINE RADIOISOTOPES; HUMANS; NEUROENDOCRINE TUMORS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 14844323979     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2004.11.001     Document Type: Review

References (51)

1. M. Findlay H. Young D. Cunningham et al. Non-invasive monitoring of tumour metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumour response to fluorouracil J Clin Oncol 14 1996 700-708
2. A.G.E. Pearse Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormone (the APUD series) and their relevance to thyroid and ultimobrachial C cells and calcitonin Proc R Soc Lond B 170 1968 7-80
3. A.G.E. Pearse The cytochemistry and ultrastructure of polypeptide hormone producing cells of the APUD series and the embryological and pathological implications of the concept J Histochem Cytochem 17 1969 303-313
4. D. Lardinois W. Weder T.F. Hany et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500-2507
5. 3]-octreotide: The Rotterdam experience with more than 1.000 patients Eur J Nucl Med 20 1993 716-731
6. M. Henze J. Schuhmacher P. Hipp et al. PET imaging of somatostatin receptors using (68 Ga) DOTA-D-Phe′-Thyr-ctreotide: First result in patients with meningiomas J Nucl Med 42 2001 1053-1056
7. E.D. Williams & M. Sandler The classification of carcinoid tumours Lancet 1 1963 238-239
8. A. Thorson G. Björck G. Björkman et al. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome Am Heart J 47 1954 795-817
9. 111 In-DTPA-D-Phe']-octreotide scintigraphy in patients with carcinoid tumours-the predictive value for somatostatin analogue treatment Eur J Endocrinol 131 1994 275-576
10. G. Kaltsas M. Korbonits & E. Heintz Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumours J Clin Endocrinol Metab 86 2001 895-902
11. H. Örlefors A. Sundin A. Lilja et al. Positron emission tomography (PET) with 5-hydroxytryptophan (5-HPT) in the diagnosis and treatment follow-up of carcinoid tumours J Clin Oncol 7 1998 2534-2541
12. H. Ahlström B. Eriksson M. Bergström et al. Pancreatic neuroendocrine tumours: Diagnosis with PET Radiology 195 1995 333-337
13. 18 F-DOPA PET for detection of gastrointestinal carcinoid tumours Radiology 220 2001 373-380
14. B. Eriksson M. Bergström H. Örlefors et al. PET for clinical diagnosis and research in neuroendocrine tumours In M.P. Sandler E.R. Coleman J.A. Patton F.J. Wackers & A. Gottschalk (eds.) Diagnosis in nuclear medicine 4th edn 2003 Lippincott & Wilkins Philadelphia 747-754
15. 18F-fluorodeoxyglucose positron emission tomography detect tumours with poor prognosis and aggressive behaviour World J Surg 22 1998 588-592
16. K. Pacak W.M. Linehan G. Eisenhofer et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma Ann Intern Med 134 2001 315-329
17. S. Maurea A. Cuocolo J.C. Reynolds et al. Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: Comparison with CT and MRI J Nucl Med 34 1993 173-179
18. B.L. Shulkin D.M. Wieland M. Schwaiger et al. PET scanning with hydroxyephedrine: An approach to the localization of pheochromocytoma J Nucl Med 33 1992 1125-1131
19. B. Shapiro M.D. Gross & B. Shulkin Radioisotope diagnosis and therapy of malignant pheochromocytoma Trends Endocrinol Metab 12 2001 469-475
20. 18 F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma Hypertension 38 2001 6-8
21. K. Pacak G. Eisenhofer & D.S. Goldstein Functional imaging of endocrine tumours: Role of positron emission tomography Endocr Rev 25 2004 568-580
22. E. Van der Harst W.W. de Herder H.A. Bruining et al. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas J Clin Endocrinol Metab 86 2001 685-893
23. B.L. Shulkin N.W. Thompson B. Shapiro et al. Pheochromocytomas: Imaging with 2-[fluorine-18] fluoro-2-dexo-d-glucose PET Radiology 212 1999 35-41
24. D. Kwekkeboom M. de Joung & E.P. Krenning Somatostatin receptor scintigraphy In M.P. Sandler E.R. Coleman J.A. Patton F.J. Wackers & A. Gottshalk (eds.) Diagnosis in nuclear medicine 4th edn 2003 Lippincott & Wilkins Philadelphia 747-754
25. D.J. Kwekkeboom H. van Urk K.H. Pauw et al. Octreotide scintigraphy for the detection of paragangliomas J Nucl Med 34 1993 873-878
26. C. Trampal H. Engler C. Juhlin et al. Detection of pheochromocytomas using 11-C-hydroxyephedrine-PET Radiology 230 2004 423-428
27. R.J. Kloos M.D. Gross I.R. Francis et al. Incidentally discovered adrenal masses Endocr Rev 16 1995 460-484
28. M. Korobkin F.J. Brodeur G.G. Yutzy et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values AJR Am J Roentgenol 166 1996 531-536
29. D.G. Mitchell M. Crovello T. Matteucci et al. Benign adrenocortical masses: Diagnosis with chemical shift MR imaging Radiology 185 1992 345-351
30. S. Gröndahl B. Eriksson L. Hagenäs et al. Steroid profile in urine: A useful tool in the diagnosis and follow-up of adrenocortical carcinoma Acta Endocrinol 122 1990 656-663
31. G.W. Boland M.A. Goldberg M.J. Lee et al. Indeterminate adrenal mass in patients with cancer: Evaluation at PET with 2-[F-18]-fluoro-2-deoxy-d -glucose Radiology 194 1995 131-134
32. M. Yun W. Kim N. Alnafisi et al. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI J Nucl Med 42 2001 1795-1799
33. M.W. Weber J. Lang F. Abedinpour et al. Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis Clin Investig 71 1993 933-938
34. 11C-metomidate J Nucl Med 41 2000 275-282
35. 11C-metomidate-PET imaging of adrenocortical cancer Eur J Nucl Med 30 2003 403-410
36. D.W. Ball S.B. Beylin & A.C. de Bustros Medullary thyroid carcinoma In L.E. Braverman & R.D. Utiger (eds.) Werner and Ingbar's the thyroid: A fundamental and clinical text 8th edn 2000 Lippincott Williams & Wilkins Philadelphia 930-943
37. J.A. van Heerden C.S. Grant H. Gharib et al. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma Ann Surg 212 1990 395-400
38. J.D.I. Ellenhorn J.P. Shali & M.F. Brennan Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid Surgery 114 1993 1078-1081
39. N.H. Martin & M.P. Sandler Thyroid imaging In M.P. Sandler E.R. Coleman J.A. Patton F.J. Wackers & A. Gottschalk (eds.) Diagnosis in nuclear medicine 4th edn 2003 Lippincott Williams & Wilkins Philadelphia 607-651
40. C.M. O'Driscoll F. Baker M.J. Casey et al. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: A case report J Nucl Med 32 1991 2281-2283
41. F.S. Conti J.M. Durski F. Bacgai et al. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography Thyroid 9 1999 797-804
42. J.A. von Heerden & C.S. Grant Surgical treatment of primary hyperparathyroidism: An institutional perspective World J Surg 15 1991 688-692
43. J. Auguste J.N. Attie & D. Schnaap Initial failure of surgical exploration in patients with primary hyperparathyroidism Am J Surg 160 1990 333-336
44. A. Giordano D. Rubello & D. Casara New trends in parathyroid scintigraphy Eur J Nucl Med 28 2001 1409-1420
45. L.B. Arkles Preoperative localization of parathyroid adenomas: The protagonist's view Intern Med 32 2002 179-182
46. N.D. Perrier P.H. Ituarte E. Morita et al. Parathyroid surgery: separating promise from reality J Clin Endocrinol Metab 87 2002 1024-1029
47. M.J. O'Doherty A.G. Kettle P. Wells et al. Parathyroid imaging with technetium-99m-sestamibi: Preoperative localization and tissue uptake studies Nucl Med 33 1992 313-318
48. A. Sundin C. Johansson P. Hellman et al. PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism J Nucl Med 37 1996 1766-1770
49. C. Muhr & M. Bergström Positron emission tomography applied in the study of pituitary adenomas J Endocrinol Invest 14 1991 509-528
50. M. Bergström C. Muhr S. Jossan et al. Differentiation of pituitary adenoma and meningioma: Visualization with positron emission tomography and [11C]-L-deprenyl Neurosurgery 30 1992 855-861
51. C. Muhr M. Bergström P.O. Lundberg et al. Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone J Comput Assist Tomogr 10 1986 175-180